|

IRL757 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Integrative Research Laboratories AB1

Indications

  • PARKINSON DISEASE (Disorder)1
  • Apathy1
  • Parkinson's Disease1
  • Safety1

Other1 trial

Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.